ANDA 91145, held by Aiping Pharm Inc. Folic Acid.
As of Nov 15, 2026, ANDA 91145 (Folic Acid), held by Aiping Pharm Inc, was first approved by FDA on Jul 12, 2013, with 0 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Folic acid is effective in the treatment of megaloblastic anemias due to a deficiency of folic acid (as may be seen in tropical or nontropical sprue) and in anemias of nutritional origin, pregnancy, infancy, or childhood.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 12, 2013 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Folic Acid1MG · tablet;oral | Folic Acid | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
